EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isoprenaline alleviates diabetic kidney disease via multi-target inhibition of the cGAS–STING pathway

Runtao Ma, Yue Song, Lijun Zhang, Peng Wang, Jiaqi Chen, Tianqi Chen, Guangyao Zhu, Qingrong Pan, Mengyu Ma, Qigui Mo, Surui Lu, Xuanjie Yu und 1 weitere

Bioscience Reports · 20.05.2026 · 46 (5)

DOI: 10.1042/bsr20250174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 05.05.2026. Verfasst von Runtao Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Nucleotidyltransferases, Membrane Proteins, Isoproterenol. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National College Student Innovation and Entrepreneurship Training Program, Hubei University of Science and Technology Development Fund Project, Hubei Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is a common microvascular complication of diabetes and is closely linked to chronic inflammation. The present study examined how the β-adrenergic receptor agonist isoprenaline (ISO) protected against DKD by regulating the cyclic GMP–AMP synthase–stimulator of interferon genes (cGAS–STING) signaling pathway through multiple targets. In a streptozotocin-induced diabetic mouse model, ISO treatment improved glomerulosclerosis, reduced podocyte injury and proteinuria, and suppressed renal inflammation. Network pharmacology and molecular docking suggested that, besides activating ADRB1/2, ISO may interact with AKT1, SRC, GSK3β, and EGFR, which are involved in cGAS–STING signaling regulation. These findings indicate that ISO alleviates DKD by inhibiting excessive activation of the cGAS–STING pathway through multi-target coordination, providing a new perspective for therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesNucleotidyltransferasesMembrane ProteinsIsoproterenolDiabetes Mellitus, ExperimentalAdrenergic beta-AgonistsAnimalscGAS-STING Signaling PathwaySTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseHumansMiceSignal TransductionMalePodocytesProto-Oncogene Proteins c-aktGlycogen Synthase Kinase 3 betaMice, Inbred C57BL

Stichwörter der Autor:innen

Diabetic kidney diseaseInflammatory responseIsoprenalinecGAS–STING pathway

Substanzen

STING ProteinNucleotidyltransferasesMembrane ProteinsIsoproterenolCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSting1 protein, mousecGAS protein, mouseProto-Oncogene Proteins c-aktGlycogen Synthase Kinase 3 betaAdrenergic beta-Agonists

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.
  • School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.
  • Radiology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437100, China.

ORCID-Profile: Yi Guo

Förderung

  • National College Student Innovation and Entrepreneurship Training Program
  • Hubei University of Science and Technology Development Fund Project
  • Hubei Provincial Natural Science Foundation of China
  • Hubei Provincial Department of Education Youth Talent Scientific Research Program

Zitieren

APA

Ma, R., Song, Y., Zhang, L., Wang, P., Chen, J., Chen, T., Zhu, G., Pan, Q., Ma, M., Mo, Q., Lu, S., Yu, X., & Guo, Y. (2026). Isoprenaline alleviates diabetic kidney disease via multi-target inhibition of the cGAS–STING pathway. Bioscience Reports, 46(5). https://doi.org/10.1042/bsr20250174

Vancouver

Ma R, Song Y, Zhang L, Wang P, Chen J, Chen T, et al. Isoprenaline alleviates diabetic kidney disease via multi-target inhibition of the cGAS–STING pathway. Bioscience Reports. 2026;46(5). doi:10.1042/bsr20250174

BibTeX
@article{Ma2026,
  author = {Ma, Runtao and Song, Yue and Zhang, Lijun and Wang, Peng and Chen, Jiaqi and Chen, Tianqi and Zhu, Guangyao and Pan, Qingrong and Ma, Mengyu and Mo, Qigui and Lu, Surui and Yu, Xuanjie and Guo, Yi},
  title = {Isoprenaline alleviates diabetic kidney disease via multi-target inhibition of the cGAS–STING pathway},
  journal = {Bioscience Reports},
  year = {2026},
  volume = {46},
  number = {5},
  doi = {10.1042/bsr20250174}
}
Kostenlos starten →